Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Risk factors for genital human papillomavirus among men in Tanzania

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Detection of oncogenic genital human papillomavirus (HPV) among HPV negative older and younger women after 7 years of follow-up

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Characterization of HIV-1 from patients with virological failure to a boosted protease inhibitor regimen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  4. Phylogeny and resistance profiles of HIV-1 POL sequences from rectal biopsies and blood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Women Living with HIV in high-income settings and Breastfeeding

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. The Consensus Hepatitis C Cascade of Care: standardized reporting to monitor progress toward elimination

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Hepatitis E during pregnancy: Maternal and foetal case-fatality rates and adverse outcomes—A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Genome Sequence of an Unknown Subtype of Hepatitis C Virus Genotype 6: Another Piece for the Taxonomic Puzzle

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Although chronic hepatitis C virus (HCV) infection accounts for 30% of individuals with cirrhotic livers worldwide, factors influencing disease progression are far from elucidated. The aim of this study was to determine whether the level of neutralizing antibodies (NAbs) correlated with the development of cirrhosis in patients with chronic HCV infection, genotype 1, when adjusting for estimated duration of infection.

METHODS: Thirty-nine patients with chronic hepatitis C, with either no/mild fibrosis (n = 23) or cirrhosis (n = 16) were enrolled from two university hospitals in Denmark. Duration of HCV infection was estimated based on patient information and/or anti-HCV seroconversion. Serial dilutions of purified serum/plasma derived IgGs were tested for their ability to neutralize six HCV-genotype 1 cell-culture strains. The results were expressed as the lowest IgG concentration yielding ≥50% neutralization (NAb50 -titer).

RESULTS: A significant difference in HCV NAb50 -titers among the six genotype 1a/1b recombinants was found. In patients with cirrhosis, a tendency for higher level of NAbs was observed compared to patients with no/mild fibrosis, although not statistical significant. Stratifying the two groups revealed that being infected >25 years resulted in higher levels of NAbs in both. Furthermore, by correlating estimated duration of HCV infection to NAb50 -titers a significant result was found against two recombinants.

CONCLUSION: The NAb titer does not differ significantly between HCV patients with either no/mild fibrosis or cirrhosis but show a tendency for increasing level with increased duration of infection. NAbs might contribute as a biological marker to increase the accuracy of patient based information on duration of HCV infection. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftJournal of Medical Virology
Vol/bind88
Udgave nummer10
Sider (fra-til)1791-1803
ISSN0146-6615
DOI
StatusUdgivet - jun. 2016

ID: 46365384